Topiramate recalls

The FDA has published 5 recalls involving Topiramate since 2012. The latest was reported on 10 Jan 2024. Glenmark Generics Inc. USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls5since 2012

Last 12 months0reported

Class I00% of total

Ongoing0latest 10 Jan 2024

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 20%Class III 4 80%

Why topiramate is recalled

Companies

Brands

Topiramate360%
Eprontia120%

By year

2024120%
2021120%
2014120%
2013120%
2012120%

All topiramate recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
10 Jan 2024Drug	CLASS III	Eprontia (topiramate) oral solution, 25 mg/mL recalledEprontia	Azurity Pharmaceuticals	Potency & Assay	Nationwide
1 Dec 2021Drug	CLASS III	Topiramate Tablets, USP 50 mg recalled by Unichem Pharmaceuticals UsaTopiramate	Unichem Pharmaceuticals USA	Other	Nationwide
22 Oct 2014Drug	CLASS II	Topiramate Tablets 200 mg recalled by Zydus Pharmaceuticals USATopiramate	Zydus Pharmaceuticals USA	Other	Nationwide
22 May 2013Drug	CLASS III	Glenmark Topiramate Tablets, 200 mg recalledTopiramate	Glenmark Generics Inc. USA	Other	Nationwide
22 Aug 2012Drug	CLASS III	Topiramate Tablets, 50 mg-dose blisters recalled	American Health Packaging	Packaging Defects	Nationwide

Should you stop taking Topiramate?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.